Journal of Clinical Oncology
Journal · Lippincott Williams & Wilkins · ISSN 0732-183X
174,152 papers · 4,482,432 citations · h-index 739 · impact 1.6
Journal websiteOpenAlexLung Cancer Treatments and MutationsCancer Treatment and PharmacologyCancer Genomics and DiagnosticsColorectal Cancer Treatments and StudiesCancer Immunotherapy and BiomarkersProstate Cancer Treatment and Research
Latest papers
- Contemporary Management of Relapsed or Refractory Chronic Lymphocytic LeukemiaMathias Castonguay, John F. Seymour · Journal of Clinical Oncology · 2026
- Longitudinal Change in Cardiac Function After Doxorubicin and Dexrazoxane: A Report From Children's Oncology Group ALTE11C2Erin M. Mobley, David R. Doody, Steven D. Colan et al. · Journal of Clinical Oncology · 2026
- Reply to: Therapeutic Strategy Concerns for <i>BRAF</i> V600E–Mutated Differentiated Thyroid CancerNabil F. Saba, Nofisat Ismaila, Francis Worden et al. · Journal of Clinical Oncology · 2026
- Modernizing Drug Development for Exceptional Therapies in High‑Unmet Need Diseases: A Call for Pragmatism and Patient CentricityElizabeth M. Jaffee, Timothy A. Yap · Journal of Clinical Oncology · 2026
- Should Artificial Intelligence Direct Systemic Therapy Decisions in Pancreatic Cancer?Gabriel A. Brooks, Raghav Sundar · Journal of Clinical Oncology · 2026
- Therapeutic Strategy Concerns for <i>BRAF</i> V600E–Mutated Differentiated Thyroid CancerHirotaka Suto · Journal of Clinical Oncology · 2026
- Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4Mary‐Ellen Taplin, Rahul Atul Parikh, R. Bryan Rumble et al. · Journal of Clinical Oncology · 2026
- Innovate or Be Left Behind: A Path to Prospective External Control Arms for Accelerated Oncology Drug DevelopmentSeung Min Hahn, Norman E. Sharpless, Christer Svedman et al. · Journal of Clinical Oncology · 2026
Most cited
- The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.David Cella, David S. Tulsky, Geoffrey V. Gray et al. · Journal of Clinical Oncology · 19936,060cited
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 19975,903cited
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano ClassificationBruce D. Cheson, Richard I. Fisher, Sally F. Barrington et al. · Journal of Clinical Oncology · 20145,641cited
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJoel S. Parker, Michael E. Mullins, Maggie C.U. Cheang et al. · Journal of Clinical Oncology · 20094,928cited
- Final Version of 2009 AJCC Melanoma Staging and ClassificationCharles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong et al. · Journal of Clinical Oncology · 20094,587cited
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJames C. Yao, Manal M. Hassan, Alexandria T. Phan et al. · Journal of Clinical Oncology · 20084,542cited
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerAntonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Journal of Clinical Oncology · 20064,480cited
- Revised Response Criteria for Malignant LymphomaBruce D. Cheson, Beate Pfistner, Malik E. Juweid et al. · Journal of Clinical Oncology · 20074,456cited
Profile assembled from OpenAlex, the open catalog of scholarly work. Metrics reflect OpenAlex’s coverage and may differ from other databases; “impact” is OpenAlex’s two-year mean citedness, comparable to a journal impact factor.
Your own research deserves this workspace
Search and screen literature, follow authors and journals, analyze your data, and write in your own voice — in one place.